Comparison of insulin resistance and lipid profile in clinically significant macular oedema versus non-clinically significant macular oedema in patients with type 2 diabetes mellitus

Lifestyle-related disorders, particularly diabetes, pose a significant global health challenge. Diabetic macular oedema, a microvascular complication, highlights the importance of managing insulin resistance and hyperlipidaemia for optimal clinical outcomes. Understanding the interplay between these factors is crucial for optimising therapeutic strategies and improving patient care. This cross-sectional study aimed to compare insulin resistance and lipid profiles between patients with clinically significant macular oedema and those with non-clinically significant macular oedema, both diagnosed with type 2 diabetes mellitus. This research can aid in the earlier identification and classification of macular oedema, enabling more timely and specific interventions. In general, 86 patients with type 2 diabetes mellitus and macular oedema were divided into two groups: clinically significant macular oedema and non-clinically significant macular oedema. Comprehensive demographic data, medical histories, and current medication regimens were recorded. Glycaemic control and lipid profiles were assessed, while ophthalmological evaluations included visual acuity measurements and intraocular pressure assessments. Significant differences were observed between the two groups, particularly in diabetes duration, body mass index, blood glucose levels, and lipid profiles. Patients with clinically significant macular oedema had a longer duration of diabetes, a higher body mass index, and elevated blood glucose levels. Triglyceride levels were significantly higher, while high‑density lipoprotein levels were lower in the clinically significant macular oedema group. Multivariate analysis revealed significant associations between the odds of developing clinically significant macular oedema and diabetes duration, visual acuity, and high-density lipoprotein levels, suggesting their potential as risk factors for this condition

Publication Details

Journal
International Journal of Medicine and Medical Research
Published
2025-03-23
DOI
https://doi.org/10.63341/ijmmr/1.2025.22
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of insulin resistance and lipid profile in clinically significant macular oedema versus non-clinically significant macular oedema in patients with type 2 diabetes mellitus

1 links
International Journal of Medicine and Medical Research
Retinal Diseases and Treatments
article

Comparison of insulin resistance and lipid profile in clinically significant macular oedema versus non-clinically significant macular oedema in patients with type 2 diabetes mellitus

article en

Abstract

Lifestyle-related disorders, particularly diabetes, pose a significant global health challenge. Diabetic macular oedema, a microvascular complication, highlights the importance of managing insulin resistance and hyperlipidaemia for optimal clinical outcomes. Understanding the interplay between these factors is crucial for optimising therapeutic strategies and improving patient care. This cross-sectional study aimed to compare insulin resistance and lipid profiles between patients with clinically significant macular oedema and those with non-clinically significant macular oedema, both diagnosed with type 2 diabetes mellitus. This research can aid in the earlier identification and classification of macular oedema, enabling more timely and specific interventions. In general, 86 patients with type 2 diabetes mellitus and macular oedema were divided into two groups: clinically significant macular oedema and non-clinically significant macular oedema. Comprehensive demographic data, medical histories, and current medication regimens were recorded. Glycaemic control and lipid profiles were assessed, while ophthalmological evaluations included visual acuity measurements and intraocular pressure assessments. Significant differences were observed between the two groups, particularly in diabetes duration, body mass index, blood glucose levels, and lipid profiles. Patients with clinically significant macular oedema had a longer duration of diabetes, a higher body mass index, and elevated blood glucose levels. Triglyceride levels were significantly higher, while high‑density lipoprotein levels were lower in the clinically significant macular oedema group. Multivariate analysis revealed significant associations between the odds of developing clinically significant macular oedema and diabetes duration, visual acuity, and high-density lipoprotein levels, suggesting their potential as risk factors for this condition

International Journal of Medicine and Medical Research
Openalex Percentile: Top 74%
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.